New York City Department of Citywide Administrative Services

April 10, 2020

NJF Worldwide was contracted by DCAS to provide 3 million PCR nasopharyngeal swabs and VTM kits. NJF Worldwide manufactured the FDA approved swabs at a low-cost and in a timely manner, even when large corporations were having difficulty procuring the materials due to the testing supply shortage. New York City Department of Citywide Administrative Services

 

As we all know, the COVID-19 pandemic brought numerous unprecedented challenges to cities, states and countries worldwide. When diagnostic testing became an integral part of the fight against Covid19, supply chain shortages combined with the multitude of individuals that needed to be tested, forced many governments, labs, and other agencies to scramble to find an ample amount of testing supplies. This testing supply shortage caused delays in the diagnosis and treatment of patients which many believe aided in the quick spread of the highly contagious coronavirus. Hospital administrators explained that their organizations were “unable to keep up with testing demands because they lacked complete kits and/or the individual components and supplies needed to complete tests, such as nasal swabs, viral transport medium (VTM), and reagents used to detect the virus.” 

 

In New York City, the Department of Citywide Administrative Services (DCAS) is responsible for ensuring that city government agencies have the resources and support they need to succeed. At the start of the pandemic, DCAS was tasked with finding numerous Covid-19 supplies including various PPE and testing materials to combat the spread of the virus. Due to supply chain shortages, government agencies were forced to use multiple vendors in order to meet the supply necessary to perform the magnitude of tests that were needed. 

 

In June of 2020, NJF Worldwide was contracted by DCAS to provide 3 million PCR nasopharyngeal swabs and VTM kits. Being that NJF Worldwide is a cofounder of Shanghai Newyar, a viral transport medium manufacturing company, they were able to direct manufacture, package and ship the 3 million requested swabs to aid in the fight against the testing supply shortage. With assistance from our global partners, NJF Worldwide was able to manufacture the FDA approved swabs at a low-cost and in a timely manner, even when large corporations were having a difficult time procuring the necessary materials.